Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-015-3338-y.

Title:
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer | Breast Cancer Research and Treatment
Description:
Paraffin sections from 239 cases of surgical resected mammary gland carcinomas were assessed to determine the role of BRCA1 gene methylation in sporadic triple-negative breast cancer and to evaluate the relationship between BRCA1 gene methylation and clinicopathologic features of triple-negative breast cancer in the National Cancer Center, China. Diagnostic tissues collected from patients received mastectomy in the National Cancer Center from January 1, 1999 to December 31, 2008 were reviewed. Tissue microarrays were constructed using 239 triple-negative breast cancer cases and stained with estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, cytokeratin 5/6, and epidermal growth factor receptor. Methylation status of the BRCA1 promoter was measured by methylation-specific PCR and analyzed against clinicopathologic characteristics, subtypes, and prognosis using standard statistical methods. Among the 239 triple-negative breast cancer cases, 137 (57.3 %) showed methylation of the BRCA1. According to the immunohistochemistry results, triple-negative breast cancer cases were classified into basal-like breast cancer (60.7 %) and non-basal-like breast cancer (39.3 %). The frequency of BRCA1 methylation was significantly higher in basal-like breast cancer subtype (71.7 %) than the non-basal subtype (35.1 %). Thus, BRCA1 methylation is statistically significantly correlated with basal-like breast cancer subtype (p < 0.001). Multivariate analyses further showed that BRCA1 promoter methylation is an independently predictor of overall survival (p = 0.023; HR 2.32; 95 % CI 1.12–4.81) and disease-free survival (p = 0.022; HR 2.36; 95 % CI 1.13–4.90) in triple-negative breast cancer. Here we demonstrated that epigenetic alteration of key tumor suppressor gene can be a promising biomarker for the prognosis of triple-negative breast cancer/basal-like breast cancer. Specifically our finding revealed that BRCA1 methylation is closely associated with a significant decrease in overall survival and disease-free survival, highlighting BRCA1 promoter methylation as promising and powerful biomarkers for effect and better prognosis of DNA damaging agents for triple-negative breast cancer/basal-like breast cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cancer, breast, article, pubmed, brca, google, scholar, cas, methylation, wang, triplenegative, promoter, sporadic, basallike, subtype, central, gene, shan, survival, access, cancers, res, privacy, cookies, content, research, cases, receptor, human, prognosis, epigenetic, dna, data, information, publish, search, hypermethylation, biomarker, zhu, liu, yang, china, clinical, clin, med, kim, treat, zhang, author, analysis,

Topics {✒️}

month download article/chapter triple-negative breast cancer/basal basal/triple-negative breast cancer triple-negative breast cancer her2/neu-overexpressing phenotypes related subjects invasive breast carcinoma full article pdf triple-negative/basal human breast cancer sporadic breast cancer dna damaging agents defective dna repair dna-damaging agents dna repair defect privacy choices/manage cookies breast cancer subtype metastatic breast cancer human breast tumours sporadic breast cancers methylation-specific pcr basal epithelial phenotype brca1 promoter methylation national cancer center brca1 gene methylation cancer cell 9 selective tumor subtype van leeuwen fe european economic area diagnostic tissues collected standard statistical methods reis-filho js tilanus-linthorst mm telomeric allelic imbalance epigenetics 6 yantai yuhuangding hospital van de rijn conditions privacy policy article log statistically significantly correlated check access menke-pluymers mb anthracycline-based therapy instant access brca1-mutation carriers cpg island hypermethylation breast cancer sporadic breast disease-free survival long term survival

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer
         description:Paraffin sections from 239 cases of surgical resected mammary gland carcinomas were assessed to determine the role of BRCA1 gene methylation in sporadic triple-negative breast cancer and to evaluate the relationship between BRCA1 gene methylation and clinicopathologic features of triple-negative breast cancer in the National Cancer Center, China. Diagnostic tissues collected from patients received mastectomy in the National Cancer Center from January 1, 1999 to December 31, 2008 were reviewed. Tissue microarrays were constructed using 239 triple-negative breast cancer cases and stained with estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, cytokeratin 5/6, and epidermal growth factor receptor. Methylation status of the BRCA1 promoter was measured by methylation-specific PCR and analyzed against clinicopathologic characteristics, subtypes, and prognosis using standard statistical methods. Among the 239 triple-negative breast cancer cases, 137 (57.3 %) showed methylation of the BRCA1. According to the immunohistochemistry results, triple-negative breast cancer cases were classified into basal-like breast cancer (60.7 %) and non-basal-like breast cancer (39.3 %). The frequency of BRCA1 methylation was significantly higher in basal-like breast cancer subtype (71.7 %) than the non-basal subtype (35.1 %). Thus, BRCA1 methylation is statistically significantly correlated with basal-like breast cancer subtype (p < 0.001). Multivariate analyses further showed that BRCA1 promoter methylation is an independently predictor of overall survival (p = 0.023; HR 2.32; 95 % CI 1.12–4.81) and disease-free survival (p = 0.022; HR 2.36; 95 % CI 1.13–4.90) in triple-negative breast cancer. Here we demonstrated that epigenetic alteration of key tumor suppressor gene can be a promising biomarker for the prognosis of triple-negative breast cancer/basal-like breast cancer. Specifically our finding revealed that BRCA1 methylation is closely associated with a significant decrease in overall survival and disease-free survival, highlighting BRCA1 promoter methylation as promising and powerful biomarkers for effect and better prognosis of DNA damaging agents for triple-negative breast cancer/basal-like breast cancer.
         datePublished:2015-03-18T00:00:00Z
         dateModified:2015-03-18T00:00:00Z
         pageStart:479
         pageEnd:486
         sameAs:https://doi.org/10.1007/s10549-015-3338-y
         keywords:
             BRCA1
            Promoter methylation
            Triple-negative breast cancer
            Prognosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-015-3338-y/MediaObjects/10549_2015_3338_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-015-3338-y/MediaObjects/10549_2015_3338_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-015-3338-y/MediaObjects/10549_2015_3338_Fig3_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:150
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:X. Zhu
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. Shan
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:F. Wang
               affiliation:
                     name:CapitalBio Corporation
                     address:
                        name:CapitalBio Corporation, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Wang
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:F. Wang
               affiliation:
                     name:Yantai Yuhuangding Hospital
                     address:
                        name:Department of Pathology, Yantai Yuhuangding Hospital, Shandong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Shen
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:X. Liu
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. Wang
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Y. Yuan
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Ying
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:H. Yang
               affiliation:
                     name:Chinese Academy of Medical Sciences, Peking Union Medical College
                     address:
                        name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer
      description:Paraffin sections from 239 cases of surgical resected mammary gland carcinomas were assessed to determine the role of BRCA1 gene methylation in sporadic triple-negative breast cancer and to evaluate the relationship between BRCA1 gene methylation and clinicopathologic features of triple-negative breast cancer in the National Cancer Center, China. Diagnostic tissues collected from patients received mastectomy in the National Cancer Center from January 1, 1999 to December 31, 2008 were reviewed. Tissue microarrays were constructed using 239 triple-negative breast cancer cases and stained with estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, cytokeratin 5/6, and epidermal growth factor receptor. Methylation status of the BRCA1 promoter was measured by methylation-specific PCR and analyzed against clinicopathologic characteristics, subtypes, and prognosis using standard statistical methods. Among the 239 triple-negative breast cancer cases, 137 (57.3 %) showed methylation of the BRCA1. According to the immunohistochemistry results, triple-negative breast cancer cases were classified into basal-like breast cancer (60.7 %) and non-basal-like breast cancer (39.3 %). The frequency of BRCA1 methylation was significantly higher in basal-like breast cancer subtype (71.7 %) than the non-basal subtype (35.1 %). Thus, BRCA1 methylation is statistically significantly correlated with basal-like breast cancer subtype (p < 0.001). Multivariate analyses further showed that BRCA1 promoter methylation is an independently predictor of overall survival (p = 0.023; HR 2.32; 95 % CI 1.12–4.81) and disease-free survival (p = 0.022; HR 2.36; 95 % CI 1.13–4.90) in triple-negative breast cancer. Here we demonstrated that epigenetic alteration of key tumor suppressor gene can be a promising biomarker for the prognosis of triple-negative breast cancer/basal-like breast cancer. Specifically our finding revealed that BRCA1 methylation is closely associated with a significant decrease in overall survival and disease-free survival, highlighting BRCA1 promoter methylation as promising and powerful biomarkers for effect and better prognosis of DNA damaging agents for triple-negative breast cancer/basal-like breast cancer.
      datePublished:2015-03-18T00:00:00Z
      dateModified:2015-03-18T00:00:00Z
      pageStart:479
      pageEnd:486
      sameAs:https://doi.org/10.1007/s10549-015-3338-y
      keywords:
          BRCA1
         Promoter methylation
         Triple-negative breast cancer
         Prognosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-015-3338-y/MediaObjects/10549_2015_3338_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-015-3338-y/MediaObjects/10549_2015_3338_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-015-3338-y/MediaObjects/10549_2015_3338_Fig3_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:150
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:X. Zhu
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. Shan
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:F. Wang
            affiliation:
                  name:CapitalBio Corporation
                  address:
                     name:CapitalBio Corporation, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Wang
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:F. Wang
            affiliation:
                  name:Yantai Yuhuangding Hospital
                  address:
                     name:Department of Pathology, Yantai Yuhuangding Hospital, Shandong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Shen
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:X. Liu
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. Wang
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Y. Yuan
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Ying
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:H. Yang
            affiliation:
                  name:Chinese Academy of Medical Sciences, Peking Union Medical College
                  address:
                     name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:150
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:CapitalBio Corporation
      address:
         name:CapitalBio Corporation, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:Yantai Yuhuangding Hospital
      address:
         name:Department of Pathology, Yantai Yuhuangding Hospital, Shandong, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Medical Sciences, Peking Union Medical College
      address:
         name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:X. Zhu
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      name:L. Shan
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      name:F. Wang
      affiliation:
            name:CapitalBio Corporation
            address:
               name:CapitalBio Corporation, Beijing, China
               type:PostalAddress
            type:Organization
      name:J. Wang
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      name:F. Wang
      affiliation:
            name:Yantai Yuhuangding Hospital
            address:
               name:Department of Pathology, Yantai Yuhuangding Hospital, Shandong, China
               type:PostalAddress
            type:Organization
      name:G. Shen
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      name:X. Liu
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      name:B. Wang
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      name:Y. Yuan
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      name:J. Ying
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:H. Yang
      affiliation:
            name:Chinese Academy of Medical Sciences, Peking Union Medical College
            address:
               name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:CapitalBio Corporation, Beijing, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:Department of Pathology, Yantai Yuhuangding Hospital, Shandong, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
      name:Department of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(147)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.31s.